Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Asset Writedowns and Impairment (2018 - 2026)

Historic Asset Writedowns and Impairment for Varex Imaging (VREX) over the last 9 years, with Q1 2026 value amounting to $1.1 million.

  • Varex Imaging's Asset Writedowns and Impairment rose 12000.0% to $1.1 million in Q1 2026 from the same period last year, while for Jan 2026 it was $4.4 million, marking a year-over-year decrease of 222.22%. This contributed to the annual value of $3.8 million for FY2025, which is 2244.9% down from last year.
  • According to the latest figures from Q1 2026, Varex Imaging's Asset Writedowns and Impairment is $1.1 million, which was up 12000.0% from $800000.0 recorded in Q4 2025.
  • Over the past 5 years, Varex Imaging's Asset Writedowns and Impairment peaked at $3.7 million during Q3 2022, and registered a low of $500000.0 during Q1 2025.
  • Its 5-year average for Asset Writedowns and Impairment is $1.3 million, with a median of $1.2 million in 2022.
  • In the last 5 years, Varex Imaging's Asset Writedowns and Impairment surged by 40000.0% in 2022 and then plummeted by 6756.76% in 2023.
  • Quarter analysis of 5 years shows Varex Imaging's Asset Writedowns and Impairment stood at $2.0 million in 2022, then crashed by 55.0% to $900000.0 in 2023, then soared by 66.67% to $1.5 million in 2024, then tumbled by 46.67% to $800000.0 in 2025, then surged by 37.5% to $1.1 million in 2026.
  • Its Asset Writedowns and Impairment stands at $1.1 million for Q1 2026, versus $800000.0 for Q4 2025 and $1.4 million for Q3 2025.